120 related articles for article (PubMed ID: 2180718)
1. Follow-up of superficial bladder cancer: how to spare cystoscopies?
Vera-Donoso CD; Llopis B; Oliver F; Server G; Alonso M; Jimenez-Cruz JF
Eur Urol; 1990; 17(1):17-9. PubMed ID: 2180718
[TBL] [Abstract][Full Text] [Related]
2. [Alternatives to the cystoscopic control of bladder neoplasms].
Páez Borda A; Luján Galán M; Martín Osés E; Berenguer Sánchez A
Arch Esp Urol; 1997 Dec; 50(10):1079-83. PubMed ID: 9494196
[TBL] [Abstract][Full Text] [Related]
3. The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies.
Raitanen MP;
World J Urol; 2008 Feb; 26(1):45-50. PubMed ID: 18180926
[TBL] [Abstract][Full Text] [Related]
4. [Can the combination of bladder ultrasonography and urinary cytodiagnosis replace cystoscopy in the diagnosis and follow-up of tumors of the bladder?].
Cariou G; Maaraoui N; Cortesse A
Prog Urol; 1997 Feb; 7(1):51-5. PubMed ID: 9116739
[TBL] [Abstract][Full Text] [Related]
5. Can transabdominal ultrasonography of the bladder replace cystoscopy in the followup of superficial bladder tumors?
Vallancien G; Veillon B; Charton M; Brisset JM
J Urol; 1986 Jul; 136(1):32-4. PubMed ID: 3520026
[TBL] [Abstract][Full Text] [Related]
6. Detection of recurrent bladder tumours by transrectal and abdominal ultrasound compared with cystoscopy.
Davies AH; Cranston D; Meagher T; Fellows GJ
Br J Urol; 1989 Oct; 64(4):409-11. PubMed ID: 2684336
[TBL] [Abstract][Full Text] [Related]
7. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic efficacy of the combination of urine cytology, urine analysis and history in the follow-up of bladder carcinoma.
Meuleman EJ; Delaere KP
Br J Urol; 1988 Aug; 62(2):150-3. PubMed ID: 3408887
[TBL] [Abstract][Full Text] [Related]
9. uCyt+ test: alternative to cystoscopy for less-invasive follow-up of patients with low risk of urothelial carcinoma.
Lodde M; Mian C; Comploj E; Palermo S; Longhi E; Marberger M; Pycha A
Urology; 2006 May; 67(5):950-4. PubMed ID: 16698355
[TBL] [Abstract][Full Text] [Related]
10. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
[TBL] [Abstract][Full Text] [Related]
11. Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations.
Kassouf W; Traboulsi SL; Schmitz-Dräger B; Palou J; Witjes JA; van Rhijn BW; Grossman HB; Kiemeney LA; Goebell PJ; Kamat AM
Urol Oncol; 2016 Oct; 34(10):460-8. PubMed ID: 27368880
[TBL] [Abstract][Full Text] [Related]
12. Analysis of false-positive BTA STAT test results in patients followed up for bladder cancer.
Raitanen MP; Kaasinen E; Lukkarinen O; Kauppinen R; Viitanen J; Liukkonen T; Tammela TL;
Urology; 2001 Apr; 57(4):680-4. PubMed ID: 11306380
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
[TBL] [Abstract][Full Text] [Related]
14. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
Kumar A; Kumar R; Gupta NP
Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
[TBL] [Abstract][Full Text] [Related]
15. Bladder cancer biomarkers and their role in surveillance and screening.
Van Tilborg AA; Bangma CH; Zwarthoff EC
Int J Urol; 2009 Jan; 16(1):23-30. PubMed ID: 19120523
[TBL] [Abstract][Full Text] [Related]
16. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of nonlinear optimization for scheduling of follow-up cystoscopies to detect recurrent bladder cancer. The Bladder Cancer follow-up Group.
Kent DL; Nease RA; Sox HC; Shortliffe LD; Shachter R
Med Decis Making; 1991; 11(4):240-8. PubMed ID: 1662739
[TBL] [Abstract][Full Text] [Related]
18. [Transabdominal ultrasonography and urinary cytology in the follow-up of superficial bladder tumors].
Miján Ortiz JL; Zuluaga Gómez A; Martínez Torres JL; Puebla Ceverino M; Navarro Sánchez A
Actas Urol Esp; 1988; 12(5):411-4. PubMed ID: 3064562
[No Abstract] [Full Text] [Related]
19. [Diagnosis and follow-up of superficial bladder tumors using non-invasive techniques].
Zuloaga Gómez A; Luis Ortiz J; Nogueras Ocaña M; Fernández Mena J; Martínez Torres JL
Arch Esp Urol; 1990; 43 Suppl 1():21-3. PubMed ID: 2078064
[TBL] [Abstract][Full Text] [Related]
20. Role of urinary NMP-22 combined with urine cytology in follow-up surveillance of recurring superficial bladder urothelial carcinoma.
Mansoor I; Calam RR; Al-Khafaji B
Anal Quant Cytol Histol; 2008 Feb; 30(1):25-32. PubMed ID: 18459584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
